[Federal Register: April 12, 2004 (Volume 69, Number 70)]
[Notices]
[Page 19191-19192]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr12ap04-53]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-46-04]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 498-1210. Send written
comments to CDC, Desk Officer, Human Resources and Housing Branch, New
Executive Office Building, Room 10235, Washington, DC 20503 or by fax
to (202) 395-6974. Written comments should be received within 30 days
of this notice.
Proposed Project: Surveillance for Bloodstream and Vascular Access
Infections in Outpatient Hemodialysis Centers, (OMB No. 0920-0442)--
Extension--National Center for Infectious Diseases (NCID), Centers for
Disease Control and Prevention (CDC).
CDC is proposing an extension of a surveillance survey of
bloodstream infections, vascular access infections, infections caused
by hospitalization, and antimicrobial infections, all of which starts
at U.S. outpatient hemodialysis centers. Although bloodstream and
vascular access infections are common in hemodialysis patients, prior
to this system there was no previous system to record and track these
complications.
Participation in the proposed project is voluntary. Currently about
80-90 centers report data each month. We estimate that about 100 of the
approximately 4,500 U.S. outpatient hemodialysis centers will
participate in the coming years.
Participating centers may collect data continuously, or may
discontinue participation at any time. CDC estimates that the average
center will participate for nine months. Each month, participating
centers will record the number of hemodialysis patients they treat and
maintain a log of all hospitalizations and intravenous (IV)
antimicrobial starts. For each hospitalization or IV antimicrobial
start, further information (e.g., type of vascular access, clinical
symptoms, presence of a vascular access infection, and blood culture
results) will be collected. These data may be reported to CDC on paper
forms or via a secure Internet site. CDC aggregates this data and
generates reports which are sent to participating dialysis centers.
Centers that participate in the Internet-based reporting system may
also analyze their own data and print out reports as desired. Rates of
bloodstream infection, vascular access infection, and antimicrobial use
per 1,000 patient-days will be calculated. Also, the percentage of
antimicrobial starts for which a blood culture is performed will be
calculated. Through use of these data, dialysis centers will be able to
track rates of key infectious complications of hemodialysis. This will
facilitate quality control improvements to reduce the incidence of
infections, and clinical practice guidelines to improve use of
antimicrobials. The estimated annualized burden is 6,300 hours.
[[Page 19192]]
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Form respondents responses per response (in
respondent hrs.)
----------------------------------------------------------------------------------------------------------------
Agreement to Participate and Practices Survey................... 100 1 1
Census Form..................................................... 100 12 1
Log............................................................. 100 10 1
Incident Form................................................... 100 200 12/60
----------------------------------------------------------------------------------------------------------------
Dated: April 1, 2003.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 04-8184 Filed 4-9-04; 8:45 am]
BILLING CODE 4163-18-P